IBDEI1LD ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25793,1,3,0)
 ;;=3^Inhalant Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,25793,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,25793,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,25794,0)
 ;;=F18.21^^92^1177^25
 ;;^UTILITY(U,$J,358.3,25794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25794,1,3,0)
 ;;=3^Inhalant Use D/O,Mod/Sev,In Remission
 ;;^UTILITY(U,$J,358.3,25794,1,4,0)
 ;;=4^F18.21
 ;;^UTILITY(U,$J,358.3,25794,2)
 ;;=^5003393
 ;;^UTILITY(U,$J,358.3,25795,0)
 ;;=F18.11^^92^1177^24
 ;;^UTILITY(U,$J,358.3,25795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25795,1,3,0)
 ;;=3^Inhalant Use D/O,Mild,In Remission
 ;;^UTILITY(U,$J,358.3,25795,1,4,0)
 ;;=4^F18.11
 ;;^UTILITY(U,$J,358.3,25795,2)
 ;;=^5151305
 ;;^UTILITY(U,$J,358.3,25796,0)
 ;;=Z00.6^^92^1178^1
 ;;^UTILITY(U,$J,358.3,25796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25796,1,3,0)
 ;;=3^Exam Control in Clinical Research
 ;;^UTILITY(U,$J,358.3,25796,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,25796,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,25797,0)
 ;;=F45.8^^92^1179^13
 ;;^UTILITY(U,$J,358.3,25797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25797,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,25797,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,25797,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,25798,0)
 ;;=F45.0^^92^1179^12
 ;;^UTILITY(U,$J,358.3,25798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25798,1,3,0)
 ;;=3^Somatization D/O
 ;;^UTILITY(U,$J,358.3,25798,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,25798,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,25799,0)
 ;;=F45.9^^92^1179^14
 ;;^UTILITY(U,$J,358.3,25799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25799,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Unspec
 ;;^UTILITY(U,$J,358.3,25799,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,25799,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,25800,0)
 ;;=F45.1^^92^1179^11
 ;;^UTILITY(U,$J,358.3,25800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25800,1,3,0)
 ;;=3^Somatic Symptom D/O
 ;;^UTILITY(U,$J,358.3,25800,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,25800,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,25801,0)
 ;;=F44.4^^92^1179^4
 ;;^UTILITY(U,$J,358.3,25801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25801,1,3,0)
 ;;=3^Conversion D/O w/ Motor Symp or Deficit
 ;;^UTILITY(U,$J,358.3,25801,1,4,0)
 ;;=4^F44.4
 ;;^UTILITY(U,$J,358.3,25801,2)
 ;;=^5003579
 ;;^UTILITY(U,$J,358.3,25802,0)
 ;;=F44.6^^92^1179^1
 ;;^UTILITY(U,$J,358.3,25802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25802,1,3,0)
 ;;=3^Conversion D/O w/ Anesthesia or Sensory Loss
 ;;^UTILITY(U,$J,358.3,25802,1,4,0)
 ;;=4^F44.6
 ;;^UTILITY(U,$J,358.3,25802,2)
 ;;=^5003581
 ;;^UTILITY(U,$J,358.3,25803,0)
 ;;=F44.5^^92^1179^2
 ;;^UTILITY(U,$J,358.3,25803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25803,1,3,0)
 ;;=3^Conversion D/O w/ Attacks or Seizures
 ;;^UTILITY(U,$J,358.3,25803,1,4,0)
 ;;=4^F44.5
 ;;^UTILITY(U,$J,358.3,25803,2)
 ;;=^5003580
 ;;^UTILITY(U,$J,358.3,25804,0)
 ;;=F44.7^^92^1179^3
 ;;^UTILITY(U,$J,358.3,25804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25804,1,3,0)
 ;;=3^Conversion D/O w/ Mixed Symptoms
 ;;^UTILITY(U,$J,358.3,25804,1,4,0)
 ;;=4^F44.7
 ;;^UTILITY(U,$J,358.3,25804,2)
 ;;=^5003582
 ;;^UTILITY(U,$J,358.3,25805,0)
 ;;=F68.10^^92^1179^7
 ;;^UTILITY(U,$J,358.3,25805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25805,1,3,0)
 ;;=3^Factitious D/O Imposed on Self,Unspec
